Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. （開啟新視窗）

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

來源‎: Hemoglobin 2014;38(1):44-8.

檢索‎: PubMed 24144212

DOI碼‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 （開啟新視窗）

Hydroxyurea in thalassemia intermedia--a promising therapy. （開啟新視窗）

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

來源‎: Ann Hematol 2005;84(7):441-6.

檢索‎: PubMed 15838670

DOI碼‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 （開啟新視窗）

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. （開啟新視窗）

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

來源‎: J Clin Pathol 2010;63(2):147-50.

檢索‎: PubMed 20154037

DOI碼‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 （開啟新視窗）

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. （開啟新視窗）

Karimi M, Borzouee M, Mehrabani A, Cohan N.

來源‎: Eur J Haematol 2009;82(3):213-8.

檢索‎: PubMed 19077048

DOI碼‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 （開啟新視窗）

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. （開啟新視窗）

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

來源‎: Eur J Haematol 2010;84(1):52-8.

檢索‎: PubMed 19799627

DOI碼‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 （開啟新視窗）

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. （開啟新視窗）

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

來源‎: Blood Cells Mol Dis 2000;26(5):453-66.

檢索‎: PubMed 11112383

DOI碼‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 （開啟新視窗）

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. （開啟新視窗）

Perrine SP.

來源‎: Pediatr Ann 2008;37(5):339-46.

檢索‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 （開啟新視窗）

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. （開啟新視窗）

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

來源‎: Ann N Y Acad Sci 2005;1054:250-6.

檢索‎: PubMed 16339672

DOI碼‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 （開啟新視窗）

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. （開啟新視窗）

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

來源‎: Acta Haematol 2004;111(4):189-95.

檢索‎: PubMed 15153710

DOI碼‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 （開啟新視窗）

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. （開啟新視窗）

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

來源‎: Blood Purif 2004;22(5):453-60.

檢索‎: PubMed 15359104

DOI碼‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 （開啟新視窗）

The role of recombinant human erythropoietin in the treatment of thalassemia. （開啟新視窗）

Rachmilewitz EA, Aker M.

來源‎: Ann N Y Acad Sci 1998;850:129-38.

檢索‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 （開啟新視窗）

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. （開啟新視窗）

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

來源‎: Br J Haematol 2011;154(2):281-4.

檢索‎: PubMed 21496003

DOI碼‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 （開啟新視窗）

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. （開啟新視窗）

Thein SL.

來源‎: Blood Rev 2012;26 Suppl 1:S35-9.

檢索‎: PubMed 22631042

DOI碼‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 （開啟新視窗）